home.social
Sign in Create account

#optionagreement — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #optionagreement, aggregated by home.social.

  1. Africa @[email protected] ·

    europesays.com/africa/223983/ General Copper Gold Option Agreement for Namibia Prospecting License – 48,500 Hectares – News and Statistics #BaseMetals #CanadianSecuritiesExchange #DamaraMobileBelt #Exploration #FrantierMiningNamibia #GeneralCopperGold #gold #Namibia #NamibiaProspectingLicense #OptionAgreement #OtjozondjupaRegion #tin #uranium

    #uranium #tin #otjozondjuparegion #optionagreement #namibiaprospectinglicense #namibia
  2. Africa @[email protected] ·

    europesays.com/africa/219789/ General Copper Gold options Namibia license, seeks C$1.5M #C$15MFinancing #CopperGold #GeneralCopperGold #GNRGF #Namibia #NamibiaExplorationLicense #OptionAgreement #PercyClark #PrivatePlacement

    #privateplacement #percyclark #optionagreement #namibiaexplorationlicense #namibia #gnrgf
  3. Bytes Europe @[email protected] ·

    Elemental Royalty options Serbia assets to BHP byteseu.com/1720070/ #BHP #Copper #ELE #ElementalRoyalty #ExplorationLicenses #gold #OptionAgreement #royalties #Serbia

    #serbia #royalties #optionagreement #gold #explorationlicenses #elementalroyalty
  4. Yonhap Infomax News @[email protected] ·

    Global pharmaceutical firms are paying upfront to secure technology transfer deals with Alteogen, as demand for its subcutaneous injection platform surges; Shinhan Investment maintains a 730,000 won target price, citing strong licensing prospects despite recent patent litigation.
    #YonhapInfomax #Alteogen #TechnologyTransfer #ShinhanInvestment #OptionAgreement #TargetPrice730000Won #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #alteogen #technologytransfer #shinhaninvestment #optionagreement #targetprice730000won
  5. Yonhap Infomax News @[email protected] ·

    Global pharmaceutical firms are paying upfront to secure technology transfer deals with Alteogen, as demand for its subcutaneous injection platform surges; Shinhan Investment maintains a 730,000 won target price, citing strong licensing prospects despite recent patent litigation.
    #YonhapInfomax #Alteogen #TechnologyTransfer #ShinhanInvestment #OptionAgreement #TargetPrice730000Won #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #alteogen #technologytransfer #shinhaninvestment #optionagreement #targetprice730000won
  6. Yonhap Infomax News @[email protected] ·

    Global pharmaceutical firms are paying upfront to secure technology transfer deals with Alteogen, as demand for its subcutaneous injection platform surges; Shinhan Investment maintains a 730,000 won target price, citing strong licensing prospects despite recent patent litigation.
    #YonhapInfomax #Alteogen #TechnologyTransfer #ShinhanInvestment #OptionAgreement #TargetPrice730000Won #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #stockmarket #bonds #securities #banking #financialmarkets #economics
  7. Yonhap Infomax News @[email protected] ·

    Global pharmaceutical firms are paying upfront to secure technology transfer deals with Alteogen, as demand for its subcutaneous injection platform surges; Shinhan Investment maintains a 730,000 won target price, citing strong licensing prospects despite recent patent litigation.
    #YonhapInfomax #Alteogen #TechnologyTransfer #ShinhanInvestment #OptionAgreement #TargetPrice730000Won #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #alteogen #technologytransfer #shinhaninvestment #optionagreement #targetprice730000won